NeuroPace (NPCE) EBITDA Margin (2020 - 2026)
NeuroPace (NPCE) posted EBITDA Margin of 22.53% for Q2 2026, up 10.7% on a QoQ basis from 25.23% in Q1 2026, and up 1946.0% year-over-year from 1.1% in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) EBITDA Margin (2020 - 2026) Analysis & Trends
NeuroPace has reported EBITDA Margin for 7 years, with the latest figure at 22.53% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 1946.0% year-over-year to 22.53% in Q2 2026; TTM through Jun 2026 was 15.26%, a 986.0% increase from a year earlier, with the FY2025 full-year figure at 16.34%, up 1078.0% from the prior year.
- EBITDA Margin was 22.53% for Q2 2026 at NeuroPace, up from 25.23% in the prior quarter.
- The five-year high for EBITDA Margin was 6.65% in Q4 2025, with the low at 107.59% in Q2 2022.
- Average EBITDA Margin over 5 years is 42.84%, with a median of 34.29% recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 7113 bps in 2022, then soared 6002 bps in 2023.
- Over 5 years, EBITDA Margin stood at 77.09% in 2022, then jumped by 64 bps to 28.04% in 2023, then jumped by 39 bps to 17.02% in 2024, then soared by 61 bps to 6.65% in 2025, then sank by 239 bps to 22.53% in 2026.
- The last three EBITDA Margin figures came in at 22.53% (Q2 2026), 25.23% (Q1 2026), and 6.65% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -22.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.53% |
| Mar 31, 2026 | -25.23% |
| Dec 31, 2025 | -6.65% |
| Sep 30, 2025 | -9.51% |
| Jun 30, 2025 | -41.99% |
| Mar 31, 2025 | -22.85% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | -20.15% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -41.63% |
| Dec 31, 2023 | -28.04% |
| Sep 30, 2023 | -36.22% |
| Jun 30, 2023 | -47.57% |
| Mar 31, 2023 | -57.48% |
| Dec 31, 2022 | -77.09% |
| Sep 30, 2022 | -91.41% |
| Jun 30, 2022 | -107.59% |
| Mar 31, 2022 | -85.83% |
| Dec 31, 2021 | -81.98% |
| Sep 30, 2021 | -60.38% |